These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: basis for dosage selection in children with meningitis. McCoig CC; Wubbel L; Jafri HS; Lutsar I; Bastero R; Olsen K; Shelton S; Friedland IR; McCracken GH J Antimicrob Chemother; 1999 May; 43(5):683-8. PubMed ID: 10382890 [TBL] [Abstract][Full Text] [Related]
9. Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy. Pea F; Pavan F; Nascimben E; Benetton C; Scotton PG; Vaglia A; Furlanut M Antimicrob Agents Chemother; 2003 Oct; 47(10):3104-8. PubMed ID: 14506016 [TBL] [Abstract][Full Text] [Related]
10. The clinical pharmacokinetics of levofloxacin. Fish DN; Chow AT Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model. Odenholt I; Cars O J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293 [TBL] [Abstract][Full Text] [Related]
12. Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis. Nau R; Zysk G; Reinert RR; Mergeryan H; Eiffert H; Prange HW J Antimicrob Chemother; 1995 Dec; 36(6):997-1004. PubMed ID: 8821598 [TBL] [Abstract][Full Text] [Related]
14. In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery. Hutschala D; Skhirtladze K; Zuckermann A; Wisser W; Jaksch P; Mayer-Helm BX; Burgmann H; Wolner E; Müller M; Tschernko EM Antimicrob Agents Chemother; 2005 Dec; 49(12):5107-11. PubMed ID: 16304179 [TBL] [Abstract][Full Text] [Related]
15. [Determination of levofloxacin in plasma and cerebrospinal fluid with HPLC and its pharmacokinetics in patients undergoing neurosurgical operations]. Luo S; Lei J; Zhang R; Cai H; Li R Yao Xue Xue Bao; 1998 Dec; 33(12):937-40. PubMed ID: 12016861 [TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci. Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741 [TBL] [Abstract][Full Text] [Related]
17. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease. Conte JE; Golden JA; McIver M; Little E; Zurlinden E Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873 [TBL] [Abstract][Full Text] [Related]
18. Diffusion of ofloxacin into the cerebrospinal fluid in patients with bacterial meningitis. Stahl JP; Croize J; Lefèbvre MA; Bru JP; Guyot A; Leduc D; Fourtillan JB; Micoud M Infection; 1986; 14 Suppl 4():S254-5. PubMed ID: 3469156 [TBL] [Abstract][Full Text] [Related]
19. High cerebrospinal fluid (CSF) penetration and potent bactericidal activity in CSF of NZ2114, a novel plectasin variant, during experimental pneumococcal meningitis. Ostergaard C; Sandvang D; Frimodt-Møller N; Kristensen HH Antimicrob Agents Chemother; 2009 Apr; 53(4):1581-5. PubMed ID: 19188395 [TBL] [Abstract][Full Text] [Related]
20. Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis. Cottagnoud P; Cottagnoud M; Acosta F; Flatz L; Kühn F; Stucki A; Entenza J Eur J Clin Microbiol Infect Dis; 2003 Nov; 22(11):656-62. PubMed ID: 14557920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]